Approximately two-thirds of Americans have received at least one dose of a COVID-19 vaccine. But COVID-19 cases remain elevated following the spread of a series of omicron sublineages, which pose a threat to those vaccinated and naturally infected with various lineages of the coronavirus. A variety of companies are developing next-generation COVID-19 vaccines that could potentially…
VRBPAC recommends expanding EUAs to authorize Janssen and Moderna boosters
The U.S. appears to be on the verge of expanding the use of COVID-19 vaccine boosters after an advisory committee backed boosters for the Johnson & Johnson (NYSE:JNJ) and Moderna (NSDQ:MRNA) vaccines. On Oct. 14 and 15, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) separately voted 19–0 to recommend boosters of both products.…